Table of Contents Author Guidelines Submit a Manuscript
Journal of Ophthalmology
Volume 2014, Article ID 582842, 9 pages
http://dx.doi.org/10.1155/2014/582842
Review Article

Age-Related Macular Degeneration: Insights into Inflammatory Genes

1Department of Biomedicine and Prevention, School of Medicine, University of Rome “Tor Vergata”, Via Montpellier 1, 00133 Rome, Italy
2UOSD Retinal Pathology PTV Foundation “Policlinico Tor Vergata”, Viale Oxford 81, 00133 Rome, Italy
3Molecular Genetics Laboratory UILDM, Santa Lucia Foundation, Via Ardeatina 354, 00142 Rome, Italy

Received 31 July 2014; Revised 23 October 2014; Accepted 23 October 2014; Published 12 November 2014

Academic Editor: Haoyu Chen

Copyright © 2014 Raffaella Cascella et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. M. Seddon and L. Sobrin, “Epidemiology of age-related macular degeneration,” in Albert & Jakobiec’s Principles and Practice of Ophthalmology, D. Albert, J. Miller, D. Azar, and B. Blodi, Eds., pp. 413–422, Saunders, Philadelphia, Pa, USA, 2007. View at Google Scholar
  2. A. Swaroop, E. Y. Chew, C. B. Rickman, and G. R. Abecasis, “Unraveling a multifactorial late-onset disease: from genetic susceptibility to disease mechanisms for age-related macular degeneration,” Annual Review of Genomics and Human Genetics, vol. 10, pp. 19–43, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. K. M. Ke, “The direct, indirect and intangible costs of visual impairment caused by neovascular age-related macular degeneration,” European Journal of Health Economics, vol. 11, no. 6, pp. 525–531, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. L. S. Lim, P. Mitchell, J. M. Seddon, F. G. Holz, and T. Y. Wong, “Age-related macular degeneration,” The Lancet, vol. 379, no. 9827, pp. 1728–1738, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. B. Gopinath, G. Liew, G. Burlutsky, and P. Mitchell, “Age-related macular degeneration and 5-year incidence of impaired activities of daily living,” Maturitas, vol. 77, no. 3, pp. 263–266, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. W. L. Wong, X. Su, X. Li et al., “Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis,” The Lancet Global Health, vol. 2, no. 2, pp. e106–e116, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. World Health Organization, “VISION 2020: the Right to Sight, the global initiative for the elimination of avoidable blindness: magnitude and causes of visual impairment,” Fact Sheet 282, 2004. View at Google Scholar
  8. C. A. Augood, J. R. Vingerling, P. T. V. M. de Jong et al., “Prevalence of age-related maculopathy in older Europeans: the European Eye Study (EUREYE),” Archives of Ophthalmology, vol. 124, no. 4, pp. 529–535, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. R. F. Mullins, S. R. Russell, D. H. Anderson, and G. S. Hageman, “Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease,” The FASEB Journal, vol. 14, no. 7, pp. 835–846, 2000. View at Google Scholar · View at Scopus
  10. R. Van Leeuwen, C. C. W. Klaver, J. R. Vingerling, A. Hofman, and P. T. V. M. De Jong, “Epidemiology of age-related maculopathy: a review,” European Journal of Epidemiology, vol. 18, no. 9, pp. 845–854, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. G. S. Hageman, P. J. Luthert, N. H. Victor Chong, L. V. Johnson, D. H. Anderson, and R. F. Mullins, “An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration,” Progress in Retinal and Eye Research, vol. 20, no. 6, pp. 705–732, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. D. H. Anderson, R. F. Mullins, G. S. Hageman, and L. V. Johnson, “A role for local inflammation in the formation of drusen in the aging eye,” American Journal of Ophthalmology, vol. 134, no. 3, pp. 411–431, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Bok, “Evidence for an inflammatory process in age-related macular degeneration gains new support,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 20, pp. 7053–7054, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. C. W. Spraul, G. E. Lang, and H. E. Grossniklaus, “Morphometric analysis of the choroid, Bruch's membrane, and retinal pigment epithelium in eyes with age-related macular degeneration,” Investigative Ophthalmology and Visual Science, vol. 37, no. 13, pp. 2724–2735, 1996. View at Google Scholar · View at Scopus
  15. W. R. Green, “Histopathology of age-related macular degeneration,” Molecular vision, vol. 5, article 27, 1999. View at Google Scholar · View at Scopus
  16. P. V. Algvere and S. Seregard, “Drusen maculopathy: a risk factor for AMD. Can we prevent visual loss?” Acta Ophthalmologica Scandinavica, vol. 81, no. 5, pp. 427–429, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. T. R. Friberg, R. A. Bilonick, and P. M. Brennen, “Risk factors for conversion to neovascular age-related macular degeneration based on longitudinal morphologic and visual acuity data,” Ophthalmology, vol. 119, no. 7, pp. 1432–1437, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. W. Smith, J. Assink, R. Klein et al., “Risk factors for age-related macular degeneration: pooled findings from three continents,” Ophthalmology, vol. 108, no. 4, pp. 697–704, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. National Eye Institute, Age-Related Macular Degeneration (AMD), National Eye Institute, 2014.
  20. S. Velilla, J. J. García-Medina, A. García-Layana et al., “Smoking and age-related macular degeneration: review and update,” Journal of Ophthalmology, vol. 2013, Article ID 895147, 11 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. C. A. Curcio, C. Owsley, and G. R. Jackson, “Spare the rods, save the cones in aging and age-related maculopathy,” Investigative Ophthalmology and Visual Science, vol. 41, no. 8, pp. 2015–2018, 2000. View at Google Scholar · View at Scopus
  22. J. Fowles and E. Dybing, “Application of toxicological risk assessment principles to the chemical constituents of cigarette smoke,” Tobacco Control, vol. 12, no. 4, pp. 424–430, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. F. Roth, A. Bindewald, and F. G. Holz, “Keypathophysiologic pathways in age-related macular disease,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 242, no. 8, pp. 710–716, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. N. L. Benowitz, “Cigarette smoking and cardiovascular disease: pathophysiology and implications for treatment,” Progress in Cardiovascular Diseases, vol. 46, no. 1, pp. 91–111, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. P. J. Deisinger, T. S. Hill, and J. C. English, “Human exposure to naturally occurring hydroquinone,” Journal of Toxicology and Environmental Health Part A, vol. 47, no. 1, pp. 31–46, 1996. View at Publisher · View at Google Scholar · View at Scopus
  26. A. P. DeCaprio, “The toxicology of hydroquinone—relevance to occupational and environmental exposure,” Critical Reviews in Toxicology, vol. 29, no. 3, pp. 283–330, 1999. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Zampatti, F. Ricci, A. Cusumano, L. T. Marsella, G. Novelli, and E. Giardina, “Review of nutrient actions on age-related macular degeneration,” Nutrition Research, vol. 34, no. 2, pp. 95–105, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. B. E. K. Klein, M. D. Knudtson, K. E. Lee et al., “Supplements and age-related eye conditions the beaver dam eye study,” Ophthalmology, vol. 115, no. 7, pp. 1203–1208, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. J. P. SanGiovanni, E. Y. Chew, T. E. Clemons et al., “The relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case-control study: AREDS report No. 22,” Archives of Ophthalmology, vol. 125, no. 9, pp. 1225–1232, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. J. R. Evans and J. G. Lawrenson, “Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration,” Cochrane Database of Systematic Reviews, vol. 6, Article ID CD000253, 2012. View at Google Scholar · View at Scopus
  31. E. W.-T. Chong, T. Y. Wong, A. J. Kreis, J. A. Simpson, and R. H. Guymer, “Dietary antioxidants and primary prevention of age related macular degeneration: systematic review and meta-analysis,” British Medical Journal, vol. 335, no. 7623, pp. 755–759, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. A. E. Millen, R. Voland, S. A. Sondel et al., “Vitamin D status and early age-related macular degeneration in postmenopausal women,” Archives of Ophthalmology, vol. 129, no. 4, pp. 481–489, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. W. G. Christen, R. J. Glynn, E. Y. Chew, C. M. Albert, and J. E. Manson, “Folic acid, pyridoxine, and cyanocobalamin combination treatment and age-related macular degeneration in women: the women's antioxidant and folic acid cardiovascular study,” Archives of Internal Medicine, vol. 169, no. 4, pp. 335–341, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Kuzniarz, P. Mitchell, V. M. Flood, and J. J. Wang, “Use of vitamin and zinc supplements and age-related maculopathy: the Blue Mountains Eye Study,” Ophthalmic Epidemiology, vol. 9, no. 4, pp. 283–295, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. J. M. Seddon, J. Cote, W. F. Page, S. H. Aggen, and M. C. Neale, “The US twin study of age-related macular degeneration: relative roles of genetic and environmental influences,” Archives of Ophthalmology, vol. 123, no. 3, pp. 321–327, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. C. J. Hammond, A. R. Webster, H. Snieder, A. C. Bird, C. E. Gilbert, and T. D. Spector, “Genetic influence on early age-related maculopathy: a twin study,” Ophthalmology, vol. 109, no. 4, pp. 730–736, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. H. P. N. Scholl, M. Fleckenstein, P. C. Issa, C. Keilhauer, F. G. Holz, and B. H. F. Weber, “An update on the genetics of age-related macular degeneration,” Molecular Vision, vol. 13, pp. 196–205, 2007. View at Google Scholar · View at Scopus
  38. C. C. W. Klaver, J. J. M. Assink, R. Van Leeuwen et al., “Incidence and progression rates of age-related maculopathy: the Rotterdam Study,” Investigative Ophthalmology and Visual Science, vol. 42, no. 10, pp. 2237–2241, 2001. View at Google Scholar · View at Scopus
  39. A. Swaroop, K. E. H. Branham, W. Chen, and G. Abecasis, “Genetic susceptibility to age-related macular degeneration: a paradigm for dissecting complex disease traits,” Human Molecular Genetics, vol. 16, no. 2, pp. 174–182, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. R. J. Klein, C. Zeiss, E. Y. Chew et al., “Complement factor H polymorphism in age-related macular degeneration,” Science, vol. 308, no. 5720, pp. 385–389, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. A. O. Edwards, R. Ritter III, K. J. Abel, A. Manning, C. Panhuysen, and L. A. Farrer, “Complement factor H polymorphism and age-related macular degeneration,” Science, vol. 308, no. 5720, pp. 421–424, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. J. L. Haines, M. A. Hauser, S. Schmidt et al., “Complement factor H variant increases the risk of age-related macular degeneration,” Science, vol. 308, no. 5720, pp. 419–421, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. S. Zareparsi, K. E. H. Branham, M. Li et al., “Strong association of the Y402H variant in complement factor H at 1q32 with susceptibility to age-related macular degeneration,” The American Journal of Human Genetics, vol. 77, no. 1, pp. 149–153, 2005. View at Publisher · View at Google Scholar · View at Scopus
  44. J. Jakobsdottir, Y. P. Conley, D. E. Weeks, T. S. Mah, R. E. Ferrell, and M. B. Gorin, “Susceptibility genes for age-related maculopathy on chromosome 10q26,” The American Journal of Human Genetics, vol. 77, no. 3, pp. 389–407, 2005. View at Publisher · View at Google Scholar · View at Scopus
  45. A. Rivera, S. A. Fisher, L. G. Fritsche et al., “Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk,” Human Molecular Genetics, vol. 14, no. 21, pp. 3227–3236, 2005. View at Publisher · View at Google Scholar · View at Scopus
  46. S. Schmidt, M. A. Hauser, W. K. Scott et al., “Cigarette smoking strongly modifies the association of LOC387715 and age-related macular degeneration,” The American Journal of Human Genetics, vol. 78, no. 5, pp. 852–864, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. L. G. Fritsche, T. Loenhardt, A. Janssen et al., “Age-related macular degeneration is associated with an unstable ARMS2 (LOC387715) mRNA,” Nature Genetics, vol. 40, no. 7, pp. 892–896, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. L. G. Fritsche, W. Chen, M. Schu et al., “Seven new loci associated with age-related macular degeneration,” Nature Genetics, vol. 45, no. 4, pp. 433–439, 2013. View at Google Scholar
  49. S. M. Whitcup, A. Sodhi, J. P. Atkinson et al., “The role of the immune response in age-related macular degeneration,” International Journal of Inflammation, vol. 2013, Article ID 348092, 10 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  50. J. Ambati, J. P. Atkinson, and B. D. Gelfand, “Immunology of age-related macular degeneration,” Nature Reviews Immunology, vol. 13, no. 6, pp. 438–451, 2013. View at Publisher · View at Google Scholar · View at Scopus
  51. E. Ozaki, M. Campbell, A. S. Kiang et al., “Inflammation in age-related macular degeneration,” Advances in Experimental Medicine and Biology, vol. 801, pp. 229–235, 2014. View at Google Scholar
  52. J. V. Forrester, “Bowman lecture on the role of inflammation in degenerative disease of the eye,” Eye, vol. 27, no. 3, pp. 340–352, 2013. View at Publisher · View at Google Scholar · View at Scopus
  53. W. Ansar and S. Ghosh, “C-reactive protein and the biology of disease,” Immunologic Research, vol. 56, no. 1, pp. 131–142, 2013. View at Publisher · View at Google Scholar · View at Scopus
  54. A. Virdis, U. Dell'Agnello, and S. Taddei, “Impact of inflammation on vascular disease in hypertension,” Maturitas, vol. 78, no. 3, pp. 179–183, 2014. View at Publisher · View at Google Scholar · View at Scopus
  55. G. Novelli, P. Borgiani, E. Giardina et al., “Role of genetics in prevention of coronary atherosclerosis,” Current Opinion in Cardiology, vol. 18, no. 5, pp. 368–371, 2003. View at Publisher · View at Google Scholar · View at Scopus
  56. E. Giardina, C. Sinibaldi, and G. Novelli, “The psoriasis genetics as a model of complex disease,” Current Drug Targets: Inflammation and Allergy, vol. 3, no. 2, pp. 129–136, 2004. View at Publisher · View at Google Scholar · View at Scopus
  57. G. B. Maru, K. Gandhi, A. Ramchandani, and G. Kumar, “The role of inflammation in skin cancer,” Advances in Experimental Medicine and Biology, vol. 816, pp. 437–469, 2014. View at Google Scholar
  58. M. Bonomi, A. Patsias, M. Posner, and A. Sikora, “The role of inflammation in head and neck cancer,” Advances in Experimental Medicine and Biology, vol. 816, pp. 107–127, 2014. View at Publisher · View at Google Scholar
  59. P. Libby, “Inflammatory mechanisms: the molecular basis of inflammation and disease,” Nutrition Reviews, vol. 65, no. 3, pp. S140–S146, 2007. View at Publisher · View at Google Scholar · View at Scopus
  60. G. K. Hansson, P. Libby, U. Schönbeck, and Z.-Q. Yan, “Innate and adaptive immunity in the pathogenesis of atherosclerosis,” Circulation Research, vol. 91, no. 4, pp. 281–291, 2002. View at Publisher · View at Google Scholar · View at Scopus
  61. M. D. Turner, B. Nedjai, T. Hurst, and D. J. Pennington, “Cytokines and chemokines: at the crossroads of cell signalling and inflammatory disease,” Biochimica et Biophysica Acta—Molecular Cell Research, vol. 1843, no. 11, pp. 2563–2582, 2014. View at Publisher · View at Google Scholar
  62. C. A. Janeway Jr. and R. Medzhitov, “Innate immune recognition,” Annual Review of Immunology, vol. 20, pp. 197–216, 2002. View at Publisher · View at Google Scholar · View at Scopus
  63. R. Medzhitov and C. Janeway Jr., “Innate immunity,” The New England Journal of Medicine, vol. 343, no. 5, pp. 338–344, 2000. View at Publisher · View at Google Scholar
  64. M. Lamkanfi and V. M. Dixit, “Mechanisms and functions of inflammasomes,” Cell, vol. 157, no. 5, pp. 1013–1022, 2014. View at Publisher · View at Google Scholar · View at Scopus
  65. P. Libby, “Inflammation and cardiovascular disease mechanisms,” The American Journal of Clinical Nutrition, vol. 83, no. 2, pp. 456S–460S, 2006. View at Google Scholar · View at Scopus
  66. D. Nuzzo, P. Picone, L. Caruana et al., “Inflammatory mediators as biomarkers in brain disorders,” Inflammation, vol. 37, no. 3, pp. 639–648, 2014. View at Publisher · View at Google Scholar · View at Scopus
  67. M. T. Wong-Riley, “Energy metabolism of the visual system,” Journal of Eye and Brain, vol. 2, pp. 99–116, 2010. View at Google Scholar
  68. M. Chen, J. V. Forrester, and H. Xu, “Dysregulation in retinal para-inflammation and age-related retinal degeneration in CCL2 or CCR2 deficient mice,” PLoS ONE, vol. 6, no. 8, Article ID e22818, 2011. View at Publisher · View at Google Scholar · View at Scopus
  69. D. Harman, “About “origin and evolution of the free radical theory of aging: a brief personal history, 1954–2009”,” Biogerontology, vol. 10, no. 6, p. 783, 2009. View at Publisher · View at Google Scholar · View at Scopus
  70. S. Bank, P. S. Andersen, J. Burisch et al., “Polymorphisms in the inflammatory pathway genes TLR2, TLR4, TLR9, LY96, NFKBIA, NFKB1, TNFA, TNFRSF1A, IL6R, IL10, IL23R, PTPN22, and PPARG are associated with susceptibility of inflammatory bowel disease in a danish cohort,” PLoS ONE, vol. 9, no. 6, Article ID e98815, 2014. View at Publisher · View at Google Scholar
  71. S. Adami, A. Cavani, F. Rossi, and G. Girolomoni, “The role of interleukin-17A in psoriatic disease,” BioDrugs, 2014. View at Publisher · View at Google Scholar · View at Scopus
  72. J. M. Seddon, S. George, B. Rosner, and N. Rifai, “Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers,” Archives of Ophthalmology, vol. 123, no. 6, pp. 774–782, 2005. View at Publisher · View at Google Scholar · View at Scopus
  73. S. V. Goverdhan, S. Ennis, S. R. Hannan et al., “Interleukin-8 promoter polymorphism −251A/T is a risk factor for age-related macular degeneration,” British Journal of Ophthalmology, vol. 92, no. 4, pp. 537–540, 2008. View at Publisher · View at Google Scholar · View at Scopus
  74. Y.-Y. Tsai, J.-M. Lin, L. Wan et al., “Interleukin gene polymorphisms in age-related macular degeneration,” Investigative Ophthalmology and Visual Science, vol. 49, no. 2, pp. 693–698, 2008. View at Publisher · View at Google Scholar · View at Scopus
  75. C. Garlanda, C. A. Dinarello, and A. Mantovani, “The interleukin-1 family: back to the future,” Immunity, vol. 39, no. 6, pp. 1003–1018, 2013. View at Publisher · View at Google Scholar · View at Scopus
  76. D. Fishman, G. Faulds, R. Jeffey et al., “The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis,” The Journal of Clinical Investigation, vol. 102, no. 7, pp. 1369–1376, 1998. View at Publisher · View at Google Scholar · View at Scopus
  77. W. E. Holmes, J. Lee, W.-J. Kuang, G. C. Rice, and W. I. Wood, “Structure and functional expression of a human interleukin-8 receptor,” Science, vol. 253, no. 5025, pp. 1278–1280, 1991. View at Publisher · View at Google Scholar · View at Scopus
  78. P. M. Murphy and H. L. Tiffany, “Cloning of complementary DNA encoding a functional human interleukin-8 receptor,” Science, vol. 253, no. 5025, pp. 1280–1283, 1991. View at Publisher · View at Google Scholar · View at Scopus
  79. L.-B. Gao, X.-M. Pan, J. Jia et al., “IL-8 -251A/T polymorphism is associated with decreased cancer risk among population-based studies: Evidence from a meta-analysis,” European Journal of Cancer, vol. 46, no. 8, pp. 1333–1343, 2010. View at Publisher · View at Google Scholar · View at Scopus
  80. Y.-Y. Tsai, J.-M. Lin, L. Wan et al., “Interleukin gene polymorphisms in age-related macular degeneration,” Investigative Ophthalmology & Visual Science, vol. 49, no. 2, pp. 693–698, 2008. View at Publisher · View at Google Scholar · View at Scopus
  81. A. Simonini, M. Moscucci, D. W. M. Muller et al., “IL-8 is an angiogenic factor in human coronary atherectomy tissue,” Circulation, vol. 101, no. 13, pp. 1519–1526, 2000. View at Publisher · View at Google Scholar · View at Scopus
  82. F. Ricci, G. Staurenghi, T. Lepre et al., “Haplotypes in IL-8 gene are associated to age-related macular degeneration: a case-control study,” PLoS ONE, vol. 8, no. 6, Article ID e66978, 2013. View at Publisher · View at Google Scholar · View at Scopus
  83. S. Mélik-Parsadaniantz and W. Rostène, “Chemokines and neuromodulation,” Journal of Neuroimmunology, vol. 198, no. 1-2, pp. 62–68, 2008. View at Publisher · View at Google Scholar · View at Scopus
  84. R. Colobran, E. Pedrosa, L. Carretero-Iglesia, and M. Juan, “Copy number variation in chemokine superfamily: the complex scene of CCL3L-CCL4L genes in health and disease,” Clinical & Experimental Immunology, vol. 162, no. 1, pp. 41–52, 2010. View at Publisher · View at Google Scholar · View at Scopus
  85. N. K. Sharma, A. Gupta, S. Prabhakar, R. Singh, A. K. Bhatt, and A. Anand, “CC chemokine receptor-3 as new target for age-related macular degeneration,” Gene, vol. 523, no. 1, pp. 106–111, 2013. View at Publisher · View at Google Scholar · View at Scopus
  86. A. Takeda, J. Z. Baffi, M. E. Kleinman et al., “CCR3 is a target for age-related macular degeneration diagnosis and therapy,” Nature, vol. 460, no. 7252, pp. 225–230, 2009. View at Publisher · View at Google Scholar · View at Scopus
  87. F. Parmeggiani, F. S. Sorrentino, M. R. Romano et al., “Mechanism of inflammation in age-related macular degeneration: an up-to-date on genetic landmarks,” Mediators of Inflammation, vol. 2013, Article ID 435607, 13 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  88. L. A. Trouw and M. R. Daha, “Role of complement in innate immunity and host defense,” Immunology Letters, vol. 138, no. 1, pp. 35–37, 2011. View at Publisher · View at Google Scholar · View at Scopus
  89. R. Klein, C. E. Myers, K. J. Cruickshanks et al., “Markers of inflammation, oxidative stress, and endothelial dysfunction and the 20-year cumulative incidence of early age-related macular degeneration the beaver dam eye study,” JAMA Ophthalmology, vol. 132, no. 4, pp. 446–455, 2014. View at Publisher · View at Google Scholar · View at Scopus
  90. E. C. Schramm, S. J. Clark, M. P. Triebwasser et al., “Genetic variants in the complement system predisposing to age-related macular degeneration: a review,” Molecular Immunology, vol. 5890, no. 14, pp. 161–163, 2014. View at Google Scholar
  91. A. MacHalińska, M. P. Kawa, W. Marlicz, and B. MacHaliński, “Complement system activation and endothelial dysfunction in patients with age-related macular degeneration (AMD): possible relationship between AMD and atherosclerosis,” Acta Ophthalmologica, vol. 90, no. 8, pp. 695–703, 2012. View at Publisher · View at Google Scholar · View at Scopus
  92. S. J. Clark, P. N. Bishop, and A. J. Day, “Complement factor H and age-related macular degeneration: the role of glycosaminoglycan recognition in disease pathology,” Biochemical Society Transactions, vol. 38, no. 5, pp. 1342–1348, 2010. View at Publisher · View at Google Scholar · View at Scopus
  93. L. A. Donoso, T. Vrabec, and H. Kuivaniemi, “The role of complement factor H in age-related macular degeneration: a review,” Survey of Ophthalmology, vol. 55, no. 3, pp. 227–246, 2010. View at Publisher · View at Google Scholar · View at Scopus
  94. D. D. G. Despriet, C. C. W. Klaver, J. C. M. Witteman et al., “Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration,” The Journal of the American Medical Association, vol. 296, no. 3, pp. 301–309, 2006. View at Publisher · View at Google Scholar · View at Scopus
  95. F. Ricci, S. Zampatti, F. D'Abbruzzi et al., “Typing of ARMS2 and CFH in age-related macular degeneration: case-control study and assessment of frequency in the Italian population,” Archives of Ophthalmology, vol. 127, no. 10, pp. 1368–1372, 2009. View at Publisher · View at Google Scholar · View at Scopus
  96. J. M. Seddon, Y. Yu, E. C. Miller et al., “Rare variants in CFI, C3 and C9 are associated with high risk of advanced age-related macular degeneration,” Nature Genetics, vol. 45, no. 11, pp. 1366–1373, 2013. View at Publisher · View at Google Scholar · View at Scopus
  97. A. Thakkinstian, M. McEvoy, U. Chakravarthy et al., “The association between complement component 2/complement factor B polymorphisms and age-related macular degeneration: a HuGE review and meta-analysis,” American Journal of Epidemiology, vol. 176, no. 5, pp. 361–372, 2012. View at Publisher · View at Google Scholar · View at Scopus
  98. C. Sun, M. Zhao, and X. Li, “CFB/C2 gene polymorphisms and risk of age-related macular degeneration: a systematic review and meta-analysis,” Current Eye Research, vol. 37, no. 4, pp. 259–271, 2012. View at Publisher · View at Google Scholar · View at Scopus
  99. J. M. Seddon, R. Reynolds, J. Maller, J. A. Fagerness, M. J. Daly, and B. Rosner, “Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables,” Investigative Ophthalmology and Visual Science, vol. 50, no. 5, pp. 2044–2053, 2009. View at Publisher · View at Google Scholar · View at Scopus
  100. M. M. Markiewski and J. D. Lambris, “The role of complement in inflammatory diseases from behind the scenes into the spotlight,” American Journal of Pathology, vol. 171, no. 3, pp. 715–727, 2007. View at Publisher · View at Google Scholar · View at Scopus
  101. G. Wang, K. L. Spencer, W. K. Scott et al., “Analysis of the indel at the ARMS2 3′UTR in age-related macular degeneration,” Human Genetics, vol. 127, no. 5, pp. 595–602, 2010. View at Publisher · View at Google Scholar · View at Scopus
  102. A. Kanda, W. Chen, M. Othman et al., “A variant of mitochondrial protein LOC387715/ARMS2, not HTRA1, is strongly associated with age-related macular degeneration,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 41, pp. 16227–16232, 2007. View at Publisher · View at Google Scholar · View at Scopus
  103. G. Wang, K. L. Spencer, B. L. Court et al., “Localization of age-related macular degeneration-associated ARMS2 in cytosol, not mitochondria,” Investigative Ophthalmology and Visual Science, vol. 50, no. 7, pp. 3084–3090, 2009. View at Publisher · View at Google Scholar · View at Scopus
  104. G. Wang, K. L. Spencer, W. K. Scott et al., “Analysis of the indel at the ARMS2 3′UTR in age-related macular degeneration,” Human Genetics, vol. 127, no. 5, pp. 595–602, 2010. View at Publisher · View at Google Scholar · View at Scopus
  105. T. R. Yasuma, M. Nakamura, K. M. Nishiguchi et al., “Elevated c-reactive protein levels and ARMS2/HTRA1 gene variants in subjects without age-related macular degeneration,” Molecular Vision, vol. 16, pp. 2923–2930, 2010. View at Google Scholar · View at Scopus
  106. J. M. Seddon, G. Gensler, and B. Rosner, “C-reactive protein and CFH, ARMS2/HTRA1 gene variants are independently associated with risk of macular degeneration,” Ophthalmology, vol. 117, no. 8, pp. 1560–1566, 2010. View at Publisher · View at Google Scholar · View at Scopus
  107. F. Zeng, M. Zhang, Y. Xu, and H. Xu, “ARMS2 interference leads to decrease of proinflammatory mediators,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 251, no. 11, pp. 2539–2544, 2013. View at Publisher · View at Google Scholar · View at Scopus
  108. M. Campbell and S. L. Doyle, “An eye on the future of inflammasomes and drug development in AMD,” Journal of Molecular Medicine, vol. 91, no. 9, pp. 1059–1070, 2013. View at Publisher · View at Google Scholar · View at Scopus
  109. J. K. Dowling and L. A. J. O'Neill, “Biochemical regulation of the inflammasome,” Critical Reviews in Biochemistry and Molecular Biology, vol. 47, no. 5, pp. 424–443, 2012. View at Publisher · View at Google Scholar · View at Scopus
  110. S. L. Masters and L. A. J. O'Neill, “Disease-associated amyloid and misfolded protein aggregates activate the inflammasome,” Trends in Molecular Medicine, vol. 17, no. 5, pp. 276–282, 2011. View at Publisher · View at Google Scholar · View at Scopus
  111. K. Schroder, R. Zhou, and J. Tschopp, “The NLRP3 inflammasome: a sensor for metabolic danger?” Science, vol. 327, no. 5963, pp. 296–300, 2010. View at Publisher · View at Google Scholar · View at Scopus
  112. A. Kauppinen, H. Niskanen, T. Suuronen, K. Kinnunen, A. Salminen, and K. Kaarniranta, “Oxidative stress activates NLRP3 inflammasomes in ARPE-19 cells—implications for age-related macular degeneration (AMD),” Immunology Letters, vol. 147, no. 1-2, pp. 29–33, 2012. View at Publisher · View at Google Scholar · View at Scopus
  113. O. A. Anderson, A. Finkelstein, and D. T. Shima, “A2E induces IL-1β production in retinal pigment epithelial cells via the NLRP3 inflammasome,” PLoS ONE, vol. 8, no. 6, Article ID e67263, 2013. View at Publisher · View at Google Scholar · View at Scopus
  114. R. T. Liu, J. Gao, S. Cao et al., “Inflammatory mediators induced by amyloid-beta in the retina and RPE in vivo: implications for inflammasome activation in age-related macular degeneration,” Investigative Ophthalmology and Visual Science, vol. 54, no. 3, pp. 2225–2237, 2013. View at Publisher · View at Google Scholar · View at Scopus
  115. W. A. Tseng, T. Thein, K. Kinnunen et al., “NLRP3 inflammasome activation in retinal pigment epithelial cells by lysosomal destabilization: implications for age-related macular degeneration,” Investigative Ophthalmology and Visual Science, vol. 54, no. 1, pp. 110–120, 2013. View at Publisher · View at Google Scholar · View at Scopus
  116. R. Ehrlich, A. Harris, N. S. Kheradiya, D. M. Winston, T. A. Ciulla, and B. Wirostko, “Age-related macular degeneration and the aging eye,” Clinical Interventions in Aging, vol. 3, no. 3, pp. 473–482, 2008. View at Google Scholar · View at Scopus
  117. L. Hyman and R. Neborsky, “Risk factors for age-related macular degeneration: an update,” Current Opinion in Ophthalmology, vol. 13, no. 3, pp. 171–175, 2002. View at Publisher · View at Google Scholar · View at Scopus